To include your compound in the COVID-19 Resource Center, submit it here.

FDA accepts NDA for Shire's prucalopride to treat constipation

Shire plc (LSE:SHP; NASDAQ:SHPG) said FDA accepted for review an

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE